EcoDrugPlus

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSACIG00000009144
Gene Symbol: PTK6B
1 Cross references
160 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSACIG00000005947
Gene Symbol: PIM1
1 Cross references
250 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSACIG00000008605
Gene Symbol: PIM3
1 Cross references
196 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSACIG00000003513
Gene Symbol: RAF1A
1 Cross references
207 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSACIG00000019529
Gene Symbol: ROCK1
1 Cross references
212 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSACIG00000013925
Gene Symbol: SRC
1 Cross references
191 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSACIG00000016761
Gene Symbol: UGCG
1 Cross references
212 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSACIG00000000823
Gene Symbol: WEE1
1 Cross references
206 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSACIG00000016027
Gene Symbol: YES1
2 Cross references
197 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSACIG00000015851
Gene Symbol: ACHE
1 Cross references
232 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSACIG00000008947
Gene Symbol: ACVR2B
1 Cross references
196 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSACIG00000016699
Gene Symbol: ACVR2BA
1 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).